CORBION NV (CRBN.AS) Stock Fundamental Analysis

Europe • Euronext Amsterdam • AMS:CRBN • NL0010583399

21.02 EUR
+0.28 (+1.35%)
Last: Feb 6, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

5

Taking everything into account, CRBN scores 5 out of 10 in our fundamental rating. CRBN was compared to 73 industry peers in the Chemicals industry. CRBN has only an average score on both its financial health and profitability. CRBN is valued quite cheap, but it does not seem to be growing. With these ratings, CRBN could be worth investigating further for value investing!.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • CRBN had positive earnings in the past year.
  • In the past year CRBN had a positive cash flow from operations.
  • In the past 5 years CRBN has always been profitable.
  • CRBN had a positive operating cash flow in each of the past 5 years.
CRBN.AS Yearly Net Income VS EBIT VS OCF VS FCFCRBN.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M

1.2 Ratios

  • CRBN's Return On Assets of 4.57% is fine compared to the rest of the industry. CRBN outperforms 69.57% of its industry peers.
  • With a decent Return On Equity value of 9.14%, CRBN is doing good in the industry, outperforming 65.22% of the companies in the same industry.
  • With a decent Return On Invested Capital value of 9.22%, CRBN is doing good in the industry, outperforming 75.36% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for CRBN is in line with the industry average of 7.31%.
  • The last Return On Invested Capital (9.22%) for CRBN is above the 3 year average (6.62%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 4.57%
ROE 9.14%
ROIC 9.22%
ROA(3y)7.34%
ROA(5y)6.93%
ROE(3y)16.91%
ROE(5y)15.8%
ROIC(3y)6.62%
ROIC(5y)7.13%
CRBN.AS Yearly ROA, ROE, ROICCRBN.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

  • CRBN has a Profit Margin of 5.12%. This is in the better half of the industry: CRBN outperforms 62.32% of its industry peers.
  • CRBN's Profit Margin has improved in the last couple of years.
  • Looking at the Operating Margin, with a value of 8.70%, CRBN is in the better half of the industry, outperforming 60.87% of the companies in the same industry.
  • In the last couple of years the Operating Margin of CRBN has declined.
  • CRBN has a worse Gross Margin (26.10%) than 60.87% of its industry peers.
  • In the last couple of years the Gross Margin of CRBN has declined.
Industry RankSector Rank
OM 8.7%
PM (TTM) 5.12%
GM 26.1%
OM growth 3Y1.69%
OM growth 5Y-4.15%
PM growth 3Y26.84%
PM growth 5Y41.37%
GM growth 3Y-0.41%
GM growth 5Y-2.31%
CRBN.AS Yearly Profit, Operating, Gross MarginsCRBN.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • CRBN has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • The number of shares outstanding for CRBN has been reduced compared to 1 year ago.
  • Compared to 5 years ago, CRBN has less shares outstanding
  • The debt/assets ratio for CRBN has been reduced compared to a year ago.
CRBN.AS Yearly Shares OutstandingCRBN.AS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
CRBN.AS Yearly Total Debt VS Total AssetsCRBN.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

  • An Altman-Z score of 2.87 indicates that CRBN is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • CRBN has a Altman-Z score of 2.87. This is in the better half of the industry: CRBN outperforms 65.22% of its industry peers.
  • CRBN has a debt to FCF ratio of 4.92. This is a neutral value as CRBN would need 4.92 years to pay back of all of its debts.
  • CRBN has a better Debt to FCF ratio (4.92) than 73.91% of its industry peers.
  • CRBN has a Debt/Equity ratio of 0.39. This is a healthy value indicating a solid balance between debt and equity.
  • CRBN's Debt to Equity ratio of 0.39 is in line compared to the rest of the industry. CRBN outperforms 59.42% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.39
Debt/FCF 4.92
Altman-Z 2.87
ROIC/WACC1.39
WACC6.65%
CRBN.AS Yearly LT Debt VS Equity VS FCFCRBN.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

  • CRBN has a Current Ratio of 1.21. This is a normal value and indicates that CRBN is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of CRBN (1.21) is worse than 78.26% of its industry peers.
  • A Quick Ratio of 0.60 indicates that CRBN may have some problems paying its short term obligations.
  • CRBN has a worse Quick ratio (0.60) than 85.51% of its industry peers.
Industry RankSector Rank
Current Ratio 1.21
Quick Ratio 0.6
CRBN.AS Yearly Current Assets VS Current LiabilitesCRBN.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. Growth

3.1 Past

  • The earnings per share for CRBN have decreased strongly by -68.92% in the last year.
  • CRBN shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 49.47% yearly.
  • CRBN shows a small growth in Revenue. In the last year, the Revenue has grown by 2.95%.
  • The Revenue has been growing slightly by 5.70% on average over the past years.
EPS 1Y (TTM)-68.92%
EPS 3Y34.95%
EPS 5Y49.47%
EPS Q2Q%-74.51%
Revenue 1Y (TTM)2.95%
Revenue growth 3Y6.35%
Revenue growth 5Y5.7%
Sales Q2Q%1.33%

3.2 Future

  • CRBN is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.24% yearly.
  • CRBN is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -1.71% yearly.
EPS Next Y36.96%
EPS Next 2Y22.71%
EPS Next 3Y19.54%
EPS Next 5Y15.24%
Revenue Next Year-2.4%
Revenue Next 2Y-0.19%
Revenue Next 3Y1.19%
Revenue Next 5Y-1.71%

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CRBN.AS Yearly Revenue VS EstimatesCRBN.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B
CRBN.AS Yearly EPS VS EstimatesCRBN.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.5 1 1.5

More info and screens

Find the best growth stocksShow best growing peers

7

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 18.77 indicates a rather expensive valuation of CRBN.
  • 68.12% of the companies in the same industry are more expensive than CRBN, based on the Price/Earnings ratio.
  • CRBN is valuated rather cheaply when we compare the Price/Earnings ratio to 27.93, which is the current average of the S&P500 Index.
  • With a Price/Forward Earnings ratio of 13.87, CRBN is valued correctly.
  • CRBN's Price/Forward Earnings ratio is rather cheap when compared to the industry. CRBN is cheaper than 82.61% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of CRBN to the average of the S&P500 Index (27.77), we can say CRBN is valued rather cheaply.
Industry RankSector Rank
PE 18.77
Fwd PE 13.87
CRBN.AS Price Earnings VS Forward Price EarningsCRBN.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CRBN indicates a somewhat cheap valuation: CRBN is cheaper than 66.67% of the companies listed in the same industry.
  • CRBN's Price/Free Cash Flow ratio is rather cheap when compared to the industry. CRBN is cheaper than 92.75% of the companies in the same industry.
Industry RankSector Rank
P/FCF 12.2
EV/EBITDA 8.51
CRBN.AS Per share dataCRBN.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The decent profitability rating of CRBN may justify a higher PE ratio.
  • CRBN's earnings are expected to grow with 19.54% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.51
PEG (5Y)0.38
EPS Next 2Y22.71%
EPS Next 3Y19.54%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 3.09%, CRBN has a reasonable but not impressive dividend return.
  • Compared to an average industry Dividend Yield of 2.26, CRBN pays a bit more dividend than its industry peers.
  • CRBN's Dividend Yield is rather good when compared to the S&P500 average which is at 1.81.
Industry RankSector Rank
Dividend Yield 3.09%

5.2 History

  • The dividend of CRBN has a limited annual growth rate of 5.02%.
Dividend Growth(5Y)5.02%
Div Incr Years1
Div Non Decr Years5
CRBN.AS Yearly Dividends per shareCRBN.AS Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

  • 56.02% of the earnings are spent on dividend by CRBN. This is a bit on the high side, but may be sustainable.
  • CRBN's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP56.02%
EPS Next 2Y22.71%
EPS Next 3Y19.54%
CRBN.AS Yearly Income VS Free CF VS DividendCRBN.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M
CRBN.AS Dividend Payout.CRBN.AS Dividend Payout, showing the Payout Ratio.CRBN.AS Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

CORBION NV

AMS:CRBN (2/6/2026, 7:00:00 PM)

21.02

+0.28 (+1.35%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)N/A
Earnings (Next)02-26
Inst Owners92.92%
Inst Owner ChangeN/A
Ins Owners0.22%
Ins Owner ChangeN/A
Market Cap1.22B
Revenue(TTM)1.30B
Net Income(TTM)66.40M
Analysts78.57
Price Target24.12 (14.75%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.09%
Yearly Dividend0.71
Dividend Growth(5Y)5.02%
DP56.02%
Div Incr Years1
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.85%
PT rev (3m)5.85%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.26%
EPS NY rev (3m)0.26%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.61%
Valuation
Industry RankSector Rank
PE 18.77
Fwd PE 13.87
P/S 0.94
P/FCF 12.2
P/OCF 7.26
P/B 1.69
P/tB 1.93
EV/EBITDA 8.51
EPS(TTM)1.12
EY5.33%
EPS(NY)1.52
Fwd EY7.21%
FCF(TTM)1.72
FCFY8.2%
OCF(TTM)2.9
OCFY13.78%
SpS22.26
BVpS12.47
TBVpS10.88
PEG (NY)0.51
PEG (5Y)0.38
Graham Number17.72
Profitability
Industry RankSector Rank
ROA 4.57%
ROE 9.14%
ROCE 10.95%
ROIC 9.22%
ROICexc 9.59%
ROICexgc 10.58%
OM 8.7%
PM (TTM) 5.12%
GM 26.1%
FCFM 7.74%
ROA(3y)7.34%
ROA(5y)6.93%
ROE(3y)16.91%
ROE(5y)15.8%
ROIC(3y)6.62%
ROIC(5y)7.13%
ROICexc(3y)7.16%
ROICexc(5y)7.83%
ROICexgc(3y)8.31%
ROICexgc(5y)9.44%
ROCE(3y)7.87%
ROCE(5y)8.47%
ROICexgc growth 3Y0.82%
ROICexgc growth 5Y-11.84%
ROICexc growth 3Y3.78%
ROICexc growth 5Y-8.06%
OM growth 3Y1.69%
OM growth 5Y-4.15%
PM growth 3Y26.84%
PM growth 5Y41.37%
GM growth 3Y-0.41%
GM growth 5Y-2.31%
F-Score6
Asset Turnover0.89
Health
Industry RankSector Rank
Debt/Equity 0.39
Debt/FCF 4.92
Debt/EBITDA 1.43
Cap/Depr 80.83%
Cap/Sales 5.27%
Interest Coverage 7.23
Cash Conversion 85.5%
Profit Quality 151.21%
Current Ratio 1.21
Quick Ratio 0.6
Altman-Z 2.87
F-Score6
WACC6.65%
ROIC/WACC1.39
Cap/Depr(3y)194.04%
Cap/Depr(5y)192.31%
Cap/Sales(3y)11.51%
Cap/Sales(5y)11.48%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-68.92%
EPS 3Y34.95%
EPS 5Y49.47%
EPS Q2Q%-74.51%
EPS Next Y36.96%
EPS Next 2Y22.71%
EPS Next 3Y19.54%
EPS Next 5Y15.24%
Revenue 1Y (TTM)2.95%
Revenue growth 3Y6.35%
Revenue growth 5Y5.7%
Sales Q2Q%1.33%
Revenue Next Year-2.4%
Revenue Next 2Y-0.19%
Revenue Next 3Y1.19%
Revenue Next 5Y-1.71%
EBIT growth 1Y54.95%
EBIT growth 3Y8.15%
EBIT growth 5Y1.31%
EBIT Next Year128.83%
EBIT Next 3Y37.35%
EBIT Next 5Y26.73%
FCF growth 1Y172.18%
FCF growth 3YN/A
FCF growth 5Y21.2%
OCF growth 1Y119.09%
OCF growth 3Y101.81%
OCF growth 5Y9.98%

CORBION NV / CRBN.AS FAQ

What is the fundamental rating for CRBN stock?

ChartMill assigns a fundamental rating of 5 / 10 to CRBN.AS.


What is the valuation status of CORBION NV (CRBN.AS) stock?

ChartMill assigns a valuation rating of 7 / 10 to CORBION NV (CRBN.AS). This can be considered as Undervalued.


What is the profitability of CRBN stock?

CORBION NV (CRBN.AS) has a profitability rating of 6 / 10.


What is the earnings growth outlook for CORBION NV?

The Earnings per Share (EPS) of CORBION NV (CRBN.AS) is expected to grow by 36.96% in the next year.


How sustainable is the dividend of CORBION NV (CRBN.AS) stock?

The dividend rating of CORBION NV (CRBN.AS) is 6 / 10 and the dividend payout ratio is 56.02%.